Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Just like a yo-yo: House spins debt ceiling to mid-May

This article was originally published in Scrip

Executive Summary

If not now, Americans will soon be in some need of a sturdy neck brace – if not some serious physical therapy and antianxiety drugs – after the whiplashing from Congress' latest bungee jumping with the nation's debt limit, and more dizzying entanglements ahead on spending cuts and the impending $1 trillion sequestration, with all of those affecting the biopharma industry in one way or another.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC020163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel